Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Home/Insights/Industry context: cardiac CT in congenital disease

Industry context: cardiac CT in congenital disease

A small, specialised segment inside a large imaging market, where purchasing decisions are made for the whole hospital rather than for this population.

Cardiac imaging

The market structure

Congenital cardiac CT is a small application within cardiovascular CT, itself part of the general CT market. Scanner purchasing is a capital decision made across a hospital’s whole caseload, so congenital imaging requirements rarely drive it — they are met by capability acquired for other reasons.

The commercially distinct elements are advanced reconstruction, analysis and segmentation software, and modelling and printing services.

What is actually changing

Photon-counting detector systems represent a genuine step change in detector technology rather than an incremental improvement, with implications for dose and resolution that matter disproportionately in small patients.

AI-based reconstruction and segmentation are being integrated into scanner platforms rather than sold separately, which changes how they are evaluated — bundled algorithms are harder to assess independently.

Evaluating claims

Image quality improvements are frequently demonstrated in phantoms or in adults and extrapolated to children. Paediatric and congenital validation is a separate requirement, not an assumed consequence.

Dose reduction claims need the comparator stated: lower than what protocol, at what image quality, in what patient size.

Regulatory clearance for a reconstruction algorithm is not evidence that diagnostic accuracy is preserved at the reduced dose.

For authors

Declare vendor involvement, and name the scanner, software and version — results from one vendor’s implementation do not transfer to another’s. Report to the relevant imaging reporting standards, with full acquisition and reconstruction parameters.

In short

What to take from this.

  • Adult or phantom validation does not transfer to small patients.
  • Dose reduction claims require the comparator protocol and image quality stated.
  • Name scanner, software and version — implementations are not equivalent.

Sources

  • Regulatory frameworks for imaging software clearance
  • Imaging study reporting standards

This page reflects established understanding as at mid-2026 and is not a current-awareness service. Clinical and regulatory positions change; verify anything decision-relevant against a current source.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.